HDAC5 and the Epigenetics of Addiction
Two new studies explain the role of the epigenetic enzyme, HDAC5, in cocaine addiction and depression.
Virtual Reality and Future-Self Avatars Work Wonders for Addiction Recovery
A promising study using virtual reality in the treatment of substance use disorders has led to a new startup.
The Next Addiction: AI Companions
MIT expert says smartphone addiction is about to take an exponential leap into AI companion addiction.
Mavoglurant Effective Against Cocaine Addiction in Phase 2 Trial
The drug company, Novartis, reports a significant decline in cocaine use with mavoglurant in phase 2 trial.
Dr. Anna Lembke on Using GLP-1 Drugs to Treat Addiction
Stanford University psychiatrist, Dr. Anna Lembke, assesses the use of GLP-1 drugs for treating addictions.
Remote Interventions Crush Relapse Rates in NIHR Study
Adding remote interventions to the standard treatment dramatically reduces relapse rates for substance use disorders.